Qualaquin, the only quinine that FDA allows on the market, is too expensive
May 2007
Patients are complaining that Qualaquin, the only quinine that FDA allows on the market, is too expensive.
It's a complicated tangle. Quinine had never been approved by the FDA. It was on the market before approval was required.
When FDA finally considered studies and approved Qualaquin last year, they decided it was safe ONLY for malaria...and not for leg cramps. And they took the non-approved quinines off the market.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote